Revvity EBITDA Margin 2010-2024 | RVTY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Revvity (RVTY) over the last 10 years. The current EBITDA margin for Revvity as of September 30, 2024 is .
| Revvity EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $2.72B | $0.74B | 27.19% |
| 2024-06-30 | $2.71B | $0.71B | 26.28% |
| 2024-03-31 | $2.73B | $0.71B | 25.90% |
| 2023-12-31 | $2.75B | $0.74B | 26.86% |
| 2023-09-30 | $2.80B | $0.80B | 28.54% |
| 2023-06-30 | $2.84B | $0.85B | 29.89% |
| 2023-03-31 | $3.02B | $1.02B | 33.70% |
| 2022-12-31 | $3.31B | $1.22B | 36.90% |
| 2022-09-30 | $3.00B | $1.38B | 45.92% |
| 2022-06-30 | $3.15B | $1.41B | 44.67% |
| 2022-03-31 | $3.48B | $1.46B | 41.87% |
| 2021-12-31 | $3.83B | $1.61B | 42.07% |
| 2021-09-30 | $3.63B | $1.63B | 44.88% |
| 2021-06-30 | $3.74B | $1.68B | 45.09% |
| 2021-03-31 | $3.32B | $1.51B | 45.47% |
| 2020-12-31 | $2.66B | $1.07B | 40.33% |
| 2020-09-30 | $3.23B | $0.86B | 26.60% |
| 2020-06-30 | $2.98B | $0.69B | 23.15% |
| 2020-03-31 | $2.89B | $0.60B | 20.92% |
| 2019-12-31 | $2.88B | $0.60B | 20.87% |
| 2019-09-30 | $2.84B | $0.56B | 19.82% |
| 2019-06-30 | $2.80B | $0.55B | 19.52% |
| 2019-03-31 | $2.78B | $0.54B | 19.34% |
| 2018-12-31 | $2.78B | $0.53B | 18.98% |
| 2018-09-30 | $2.66B | $0.49B | 18.33% |
| 2018-06-30 | $2.54B | $0.47B | 18.36% |
| 2018-03-31 | $2.39B | $0.43B | 17.89% |
| 2017-12-31 | $2.26B | $0.41B | 18.17% |
| 2017-09-30 | $2.18B | $0.40B | 18.42% |
| 2017-06-30 | $2.14B | $0.40B | 18.58% |
| 2017-03-31 | $2.13B | $0.39B | 18.21% |
| 2016-12-31 | $2.12B | $0.40B | 18.77% |
| 2016-09-30 | $2.00B | $0.35B | 17.56% |
| 2016-06-30 | $2.05B | $0.35B | 17.29% |
| 2016-03-31 | $2.08B | $0.36B | 17.34% |
| 2015-12-31 | $2.11B | $0.37B | 17.34% |
| 2015-09-30 | $2.10B | $0.30B | 14.51% |
| 2015-06-30 | $2.07B | $0.29B | 13.89% |
| 2015-03-31 | $2.07B | $0.29B | 13.99% |
| 2014-12-31 | $2.07B | $0.28B | 13.48% |
| 2014-09-30 | $2.22B | $0.40B | 17.90% |
| 2014-06-30 | $2.20B | $0.40B | 18.24% |
| 2014-03-31 | $2.18B | $0.38B | 17.18% |
| 2013-12-31 | $2.16B | $0.36B | 16.74% |
| 2013-09-30 | $2.13B | $0.24B | 11.12% |
| 2013-06-30 | $2.12B | $0.22B | 10.38% |
| 2013-03-31 | $2.10B | $0.23B | 10.95% |
| 2012-12-31 | $2.11B | $0.24B | 11.25% |
| 2012-09-30 | $2.08B | $0.25B | 11.82% |
| 2012-06-30 | $2.03B | $0.24B | 11.65% |
| 2012-03-31 | $1.98B | $0.22B | 11.10% |
| 2011-12-31 | $1.92B | $0.21B | 11.05% |
| 2011-09-30 | $1.85B | $0.27B | 14.84% |
| 2011-06-30 | $1.81B | $0.27B | 15.12% |
| 2011-03-31 | $1.76B | $0.26B | 15.04% |
| 2010-12-31 | $1.70B | $0.25B | 14.63% |
| 2010-09-30 | $1.54B | $0.23B | 14.85% |
| 2010-06-30 | $1.49B | $0.20B | 13.33% |
| 2010-03-31 | $1.51B | $0.20B | 13.45% |
| 2009-12-31 | $1.55B | $0.20B | 12.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.453B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.995B | 10.55 |
| Cencora (COR) | United States | $43.734B | 16.44 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $20.871B | 0.00 |
| ICON (ICLR) | Ireland | $16.879B | 15.03 |
| Viatris (VTRS) | United States | $14.478B | 4.46 |
| Avantor (AVTR) | United States | $14.307B | 21.45 |
| BioMerieux (BMXMF) | France | $12.659B | 0.00 |
| CochLear (CHEOY) | Australia | $11.807B | 0.00 |
| Solventum (SOLV) | United States | $11.540B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
| Doximity (DOCS) | United States | $10.302B | 60.64 |
| Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
| HealthEquity (HQY) | United States | $8.212B | 41.20 |
| Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.759B | 20.11 |
| Organon (OGN) | United States | $3.719B | 3.75 |
| BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
| Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
| Concentras Parent (CON) | United States | $2.491B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| PACS (PACS) | United States | $1.992B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
| Progyny (PGNY) | United States | $1.208B | 24.47 |
| Embecta (EMBC) | United States | $1.161B | 8.12 |
| CareDx (CDNA) | United States | $1.102B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| SBC Medicals (SBC) | United States | $0.649B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| DocGo (DCGO) | United States | $0.444B | 16.73 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 33.48 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Biodesix (BDSX) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.156B | 8.44 |
| MultiPlan (MPLN) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 15.69 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.033B | 0.87 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |